CellWell record HH-583709
Transfer Factor as an Option for Managing the COVID-19 Pandemic
Viza D; Pizza G; De Vinci C; Brandi G; Ablashi D
Folia biologica ยท 2020
In plain language
This review argued that transfer factor, an immunomodulator described as devoid of toxicity, should be tested against COVID-19 because no treatment or vaccine was expected for months.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-583709
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.